AI is making significant contributions to cancer research by accelerating the drug discovery process. Machine learning models can predict how cancer cells will respond to different compounds, thereby identifying potential new drugs more quickly than traditional methods. Additionally, AI can analyze large datasets from clinical trials to identify trends and outcomes that might not be immediately apparent.
